Volume 11, Number 4—April 2005
Letter
Route of Infection in Melioidosis
Table
Route of infection | NCTC 13178 |
NCTC 13179 |
||
---|---|---|---|---|
BALB/c | C57BL/6 | BALB/c | C57BL/6 | |
Intravenous | <10 | 5 x 103 | 9 x 103 | 6 x 106 |
Intraperitoneal | 1.2 x 101 | 9.7 x 103 | 4.7 x 105 | 2.1 x 107 |
Subcutaneous | 1 x 103 | 9 x 105 | 9 x 102 | >108 |
Intranasal† | 1.4 x 102 | 1.8 x 103 | 1.9 x 106 | >108 |
Oral‡ | 7.2 x 103 | 1.8 106 | 4.8 x 106 | >108 |
*50% lethal dose.
†20 μL of challenge dose was introduced intranasally onto the nostrils of the mice by using a pipette tip.
‡20 μL of challenge dose was introduced orally to the back of the throat of the mice by using a pipette tip.
Page created: May 23, 2011
Page updated: May 23, 2011
Page reviewed: May 23, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.